|
May 30
|
J&J's (JNJ) Oral Pill Improves Depression & Insomnia Symptoms
|
|
May 29
|
Agios (AGIO) Up 23% on Selling Brain Cancer Drug Royalty
|
|
May 29
|
Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
|
|
May 28
|
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
|
|
May 27
|
Merus (MRUS) Surges 36% on Head & Neck Cancer Antibody Data
|
|
May 24
|
Iovance (IOVA) Up 5% on Updated Data From Melanoma Study
|
|
May 24
|
Analysts Are Betting On Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) With A Big Upgrade This Week
|
|
May 23
|
Pfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
|
|
May 15
|
Q1 2024 Arcutis Biotherapeutics Inc Earnings Call
|
|
May 15
|
Arcutis Biotherapeutics Inc (ARQT) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
|
|
May 14
|
Arcutis Announces First Quarter 2024 Financial Results and Provides Business Update
|
|
May 13
|
Expert Panel Review Further Validates Use of ZORYVE® (roflumilast) Topical Foam, 0.3% for Treatment of Seborrheic Dermatitis Across Diverse Hair Types Published in Journal of Clinical and Aesthetic Dermatology
|
|
Apr 29
|
Arcutis to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
|
|
Apr 26
|
Industry Analysts Just Made A Captivating Upgrade To Their Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Revenue Forecasts
|
|
Apr 24
|
Is AdaptHealth (AHCO) Stock Outpacing Its Medical Peers This Year?
|
|
Apr 10
|
Arcutis Appoints David Topper as Chief Financial Officer
|
|
Apr 8
|
Are Medical Stocks Lagging AdaptHealth (AHCO) This Year?
|
|
Apr 1
|
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
|
|
Mar 28
|
Arcutis to Present at the 23rd Annual Needham Virtual Healthcare Conference
|
|
Mar 19
|
Arcutis Biotherapeutics, Inc. (ARQT) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
|